Abstract:OBJECTIVE:To explore the appearances of digital subtraction angiography (DSA) and therapeutic efficacy of interventional therapy of hepatic carcinoma accompanied with arteriovenous shunting (AVS).METHODS:To retrospectively analyze clinical material of 97 patients with hepatocellular carcinoma with hepatic artery-portal vein shunting(HA-PVS), of whom, 16 had upper gastrointestinal hemorrhage, 51 had middle to large amounts of ascites, and 53 had varices of esophagus and fundus gastricus. All the patients were treated with transcatheter arterial chemoembolization (TACE) or transcatheter arterial infusion chemotherapy (TAI). Shunts were embolized by lipidol in 40 patients, by lipidol and sponjgia gelatinosa particle in 34 patients, and by coil in 6 patients. The remaining 17 were treated only with TAI.RESULTS:Twelve (12.4%) cases had hepatic arteryjhepatic vein shunting (HA-HVS)ìwhile 32 (33%)cases had portal vein tumor thrombosis (PVTT). In 70(72.2%) patients, all shunts were completely closed successfully, in 15(15.5%) patients, the shunts were partly closed, and in 12(12.3%)patients, the shunts were not closed. In 12 patients, the shunts reopened in later therapy, their blood flow was smaller than before and they were closed after second embolization. In 17 patients, new shunts emerged. After TACE therapy ìthe tumors were smaller in 57(58.7%)ìbigger in 24 (24.7%)ìand 16(16.5%) were the same in size before and after TACE. Ascites disappeared in 29 patients, decreased in 18 patients and had no change in 4 patients. Five patients who had upper gastrointestinal hemorrhage prejoperation had new hemorrhage. Of the 47 patients who had diarrhea, 23 improved. In 67 alpha fetoprotein (AFP) positive patients, degree of AFP in 53 patients decreased. Eighty-one patients died and their middle survival period was 12.9 months. No serious damage to hepatic function due to the treatment was observed in most patients.CONCLUSION:Primary hepatic carcinoma with AVS increases difficulty of interventional therapyìbut as long as we take active and proper treating measureìwe could acquire satisfactory curative effect without serious syndrome. DSA can demonstrate the type, the site and the degree of AVS completely and directly, thus having important value in treating primary hepatic carcinoma and improving prognosis.

Short-Term Curative Effect of Interventional Embolism on Primary Liver Carcinoma Complicated with Hepatic Arterioportal Shunting

Evaluation of the Efficacy for Alternated Treatment on Primary Liver Cancer by Interventional Therapy in Combination with Fractionated Stereotactic Conformal Radiotherapy

[Clinical Effect of Terminal Branches Portal Vein Embolization Combined with Transcatheter Arterial Chemoembolization on Liver Neoplasms].

[Analysis of Clinical Prognosis and the Correlation Between Bile Duct Injury after Transcatheter Arterial Chemoembolization and the Level of Hepatic Arterial Embolization in Patients with Hepatocellular Carcinoma].

Combined Three Intervened Treatment of TACE,PEI And PVC in Advanced Liver Cancer

Evaluation of the Curative Effect of Transcatheter Arterial Chemoembolization Via Hepatic Artery Combined with Percutaneous Ethanol Injection for the Treatment of Primary Hepatocellular Carcinoma

Imaging characteristics and intervention therapy for hepatic artery-portal vein shunts in patients with primary liver carcinoma

The Clinical Effect in Patients with Primary Liver Cancer with Well-Filled Lipiodol after Transcatheter Arterial Chemoembolization

The Role of Interventional Treatment on Hepatocellular Carcinoma Combined with Portal Vein Tumor Thrombosis

Clinical Characteristics and Outcomes of Acute Lung Injury Caused by Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma: A Retrospective Cohort Study from a Single Institution in China

Digital Subtraction Angiography Manifestation and Interventional Therapy of Arteriovenous Shunting in Primary Hepatocellular Carcinoma of Advanced Stage

Treatment of Transcatheter Arterial Embolization in a Patient with Arterioportal Shunt

Evaluation of CT-guided ~(125)I Seed Implantation Combined with Transcatheter Arterial Chemoembolization in Treating Portal Vein Tumor Thrombus Associated with Hepatocellular Carcinoma

Short-Term Effect Of Combined Therapy With Jinlong Capsule ((Sic)) And Transcatheter Arterial Chemoembolization On Patients With Primary Hepatic Carcinoma And Its Influence On Serum Osteopontin Expression

Transcatheter Arterial Chemoembolization In Combination With Stereotactic Body Radiation Therapy In Primary Liver Carcinoma: A Systematic Review And Meta-Analysis

Effect of chemotherapeutics and embolization on tumor inhibition and liver injury in TACE treatment of hepatic carcinoma

Embolization of hepatic arterio-portal shunt in patients with HCC complicated by portal vein tumor ;thrombus treated with TACE combined with portal vein stenting：its clinical significance

Therapeutic Efficacy of Transcatheter Arterial Chemoembolization for Liver Cancer with High-Risk Factors

Feasibility and Efficacy of Dose-reduced Transcatheter Arterial Chemoembolization (TACE) for Primary Liver Cancer Patients with Portal Vein Thrombosis

Transcatheter arterial chemoembolization combined with endovascular 125I seed strip implantation for primary hepatocellular carcinoma associated with portal vein tumor thrombus：analysis of curative effect

TACE Combined with Portal Vein Tumor Thrombus 125I Seed Implantation in the Treatment of HCC with Hepatic Arterioportal Shunts